Washington, D.C. 20549
Specialized Disclosure Report
ISORAY,
INC.
(Exact name of registrant as specified in
its charter)
|
|
Minnesota
(State or other jurisdiction
of incorporation)
|
001-33407
(Commission
File Number)
|
41-1458152
(IRS Employer
Identification No.)
|
350 Hills Street, Suite 106
Richland, WA
|
|
99354
|
(Address of principal executive offices)
|
|
(Zip code)
|
Brien Ragle, CFO
|
|
509.375.1202
|
(Name and telephone number, including area code, of the person to contact in connection with this report.)
|
________________
Check the appropriate box to indicate the
rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
|
x
|
Rule 13p-1 under the Securities Exchange Act (17 CFR
240.13p-1) for the reporting period from January 1 to December 31, 2015.
|
Introduction
This Specialized Disclosure Report on Form
SD (“Form SD”) of IsoRay, Inc. (“IsoRay,” the “Company” or “we”) for the year ended
December 31, 2015 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (“Rule”). Numerous
terms in this Form SD are defined in the Rule and the reader is referred to that source and to SEC Release No. 34-67716 issued
by the Securities and Exchange Commission on August 22, 2012 for such definitions.
We are a medical technology company that
develops, manufactures and markets seed brachytherapy and medical radioisotope applications for various cancers. Our brachytherapy
seeds contain a small amount of gold that is necessary to the functionality or production of those products. Our brachytherapy
seeds are manufactured in IsoRay’s own facility. Although our brachytherapy seeds contain a small amount of gold,
IsoRay does not purchase ore or unrefined conflict minerals from mines and is many steps removed in the supply chain from the mining
of the conflict minerals. We historically have purchased the gold used in our products from a single supplier. This supplier is
in the best position in the total supply chain to know the origin of the gold we use. We rely on this supplier to assist
with our reasonable country of origin inquiry for the gold contained in the materials which it supplies to us.
Section 1- Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure
and Report
Conflict Minerals Disclosure
This Form SD of IsoRay, Inc. is filed pursuant
to Rule 13p-1 promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period January 1, 2015 to December
31, 2015.
The Company manufactures products for which
a Conflict Mineral, gold, is necessary to the functionality or production of those products. The Company has conducted a good faith
reasonable country of origin inquiry regarding the Conflict Minerals. The good faith reasonable country of origin inquiry was reasonably
designed to determine whether any of the Conflict Minerals originated in the Covered Countries and whether any of the Conflict
Minerals may be from recycled or scrap sources.
For the 2015 reporting year, we contacted
our single direct supplier of gold to obtain country of origin information for the gold in our brachytherapy seeds. Our supplier
certified that all gold purchased in 2015 was from sources outside of the Covered Countries.
Conclusion
Based on this reasonable country of origin
inquiry, the Company determined that it has no reason to believe that the Conflict Minerals may have originated in the Covered
Countries. Therefore, the Company is not required to provide a conflict minerals report.
Website Disclosure
This Form SD is publicly available at www.isoray.com
as well as the SEC’s EDGAR database at www.sec.gov. The content of any website referred to in this Form SD is included for
general information only and is not incorporated by reference in this Form SD.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
IsoRay, Inc.
|
|
|
|
|
|
|
By:
|
/s/ Brien Ragle
|
May 31, 2016
|
|
|
Brien Ragle, CFO
|
(DATE)
|
|
IsoRay (AMEX:ISR)
Historical Stock Chart
From Mar 2024 to Apr 2024
IsoRay (AMEX:ISR)
Historical Stock Chart
From Apr 2023 to Apr 2024